Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 300 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
2.Enlace a cita original Cita con resumen
Hurd YL, Spriggs S, Alishayev J, Winkel G, Gurgov K, Kudrich C, Oprescu AM, Salsitz E. Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial. Am J Psychiatry 2019:21 de mayo. [Ref.ID 103125]
3.Enlace a cita original Cita con resumen
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith KM, Bisal N, Li J, Parrott S, Sasieni P, Dawkins L, Ross L, Goniewicz M, Wu Q, McRobbie HJ. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:14 de febrero. [Ref.ID 103022]
4. Cita con resumen
Benefits NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers. A randomized clinical trial. JAMA Intern Med 2018;178:622-31. [Ref.ID 102506]
6. Cita con resumen
Ostrow L, Jessell L, Hurd M, Darrow SM, Cohen D. Discontinuing psychiatric medications: a survey of long-term users . Psychiatric Services 2017;68:1232-8. [Ref.ID 101485]
7.Enlace a cita original
Henche Ruiz AI. El auge de la analgesia opioide. Problemas relacionados con su uso a largo plazo. Boletín Farmacoterapéutico de Castilla-La Mancha 2016;17:1-6. [Ref.ID 101039]
9. Cita con resumen
Middleton J, McGrail S, Stringer K. Drug related deaths in England and Wales. BMJ 2016;355:i5259. [Ref.ID 100851]
11. Cita con resumen
Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016;387:2507-20. [Ref.ID 100460]
12. Cita con resumen
Lindson-Hawley N, Banting M, West R, Michie S, Shinkins B. Gradual versus abrupt smoking cessation: a randomized, controlled noninferiority trial. Ann Intern Med 2016;164:585-92. [Ref.ID 100260]
13. Cita con resumen
Anónimo. Drugs for tobacco dependence. The Medical Letter on Drug and Therapeutics Bulletin 2016;58:27-31. [Ref.ID 100127]
14.Tiene citas relacionadas Cita con resumen
Gotzsche PC. Antidepressants are addictive and increase the risk of relapse. BMJ 2016;352:i574. [Ref.ID 100055]
15.Tiene citas relacionadas Cita con resumen
Dubicka B, Cole-King A, Reynolds S, Ramchandani P. Paper on suicidality and aggression during antidepressant treatment was flawed and the press release was misleading. BMJ 2016;352:i911. [Ref.ID 100053]
16. Cita con resumen
Dyer C. Judge might reopen GSK paroxetine case. BMJ 2016;352:i800. [Ref.ID 100045]
18.Tiene citas relacionadas Cita con resumen
Moncrieff J. Misrepresenting harms in antidepressant trials. BMJ 2016;352:i217. [Ref.ID 100033]
19. Cita con resumen
Moncrieff J. Antipsychotic maintenance treatment: time to rethink?. PLOS Medicine 2015;12:4 de agosto. [Ref.ID 99453]
20. Cita con resumen
Anónimo. Effets indésirables cardiaques des substituts nicotiniques. Prescrire 2015;35:513-4. [Ref.ID 99441]
Seleccionar todas
 
 1 a 20 de 300 siguiente >>